Question to the Department of Health and Social Care:

To ask Her Majesty’s Government whether the Department of Health in Northern Ireland has asked to be represented by them in discussions with the manufacturers of the meningitis B vaccine Bexsero.

We have had a number of meetings with the manufacturer for supply of the meningococcal B vaccine, Bexsero^® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, and we are continuing to meet.

The Department is conducting these negotiations on behalf of the devolved administrations, as is usual and agreed practice.